Stevanato Group

How Stevanato Group has responded to challenges pertaining to primary packaging of complex highly sensitive injectables

Concerns with silicone and biopharmaceutical development

 technology for high-performance pre-fillable syringe systems

How to prevent or manage concerns utilizing newer, pre-sterilized syringe systems that have more unique characteristics.

How to De-risk the Development of Highly Sensitive Injectables Using High-Performance Pre-fillable Syringe Systems

Videos

Enrico Barichello, Product Manager for the Syringe Platform at Stevanato Group, discusses the risks associated with the interaction between primary packaging and complex novel therapeutics and describes how to prevent or manage concerns utilizing newer, pre-sterilized syringe systems that have more unique characteristics. 

How to De-risk the Development of Highly Sensitive Injectables Using High-Performance Pre-fillable Syringe Systems   

Our proprietary device portfolio will include Alina® pen injector – a platform device for variable and multi-dose treatments for diabetes and obesity, together with the innovative On-Body Delivery System (OBDS) developed in collaboration with Bexson Biomedical, Inc. – showcased in the event's Innovation Gallery. The subcutaneous drug delivery system is the flagship for Bexson’s proprietary keta-mine formulation, BB106, and leverages Stevanato Group’s existing technology and broad experience in medical device innovation.

Adam Stops, Head of Product Management Drug Delivery Systems at Stevanato Group, will present, together with Richard Harrison, Product Development Manager at Owen Mumford Pharmaceutical Services, a workshop entitled "Collaborating to Simplify Device Development and Optimize Glass Solutions for Auto-Injectors".

The workshop is on 1 February from 3:40 to 4:10pm in Conference Room 725.

Our new special thin-wall needle, which we'll be unveiling at Pharmapack is a 27G ½" needle with large-diameter internal channel, designed to optimize the delivery of viscous biologics via auto-injector – avoiding the need for bigger needles and therefore improving the overall patient experience.

We look forward to welcoming you to booth #F46 for a glimpse into the future of pharma.

Articles

Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries.